MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
MBX Biosciences appointed Jeff Held, J.D., as Chief Legal Officer, bringing more than three decades of legal, compliance and executive leadership experience across biotechnology, life sciences and healthcare. Held was most recently Chief Legal Officer of Zenas BioPharma and previously served as SVP, General Counsel at Deciphera Pharmaceuticals, where he led more than $1 billion in equity financings and co-led the company's $2.4 billion acquisition by Ono Pharmaceutical.
Key figures
- Inducement rsus
- 19125
- Option term years
- 10
- Option exercise price
- 60.93
- Inducement stock options
- 89250
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.